Kindred Biosciences, Inc.
KINDelisted Aug 27, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001561743
Kindred Biosciences, Inc. was delisted on Aug 27, 2021; its insiders filed their last Form 4 on Sep 13, 2021; 87 institutions reported holding it in 13F filings for Q2 2021, worth $311.0M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kindred Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kindred Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Park West Asset Management LLC | 10% Owner | 0Indirect | Sep 13, 2021 | 0 |
| Zhan Hangjun | Chief Scientific Officer | 0 | Aug 30, 2021 | 0 |
| Montgomery Herbert D | Director | – | Aug 30, 2021 | 0 |
| Chin Richard | Chief Executive Officer | 0Indirect | Aug 30, 2021 | 0 |
| Wee Wendy | Chief Financial Officer | 0 | Aug 30, 2021 | 0 |
| Bevers Denise | Director | 0 | Aug 30, 2021 | 0 |
| Townsend Raymond | Director | 0 | Aug 30, 2021 | 0 |
| Veszpremi Ervin | Director | – | Aug 30, 2021 | 0 |
| McCracken Joseph S | Director | – | Aug 30, 2021 | 0 |
| Elanco Animal Health Inc | 10% Owner | 10,000 | Aug 30, 2021 | 0 |
| Liu Nanxi | Director | – | Aug 30, 2021 | 0 |
| Lien Lyndon | Director | – | Aug 30, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2021 (view filing) | Jul 2 | 5 days | Chin RichardChief Executive Officer | SSale | −40.0K | $9.18 | −$367.2K | −2.1%1.89M after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Chin RichardChief Executive Officer | SSale | −40.0K | $9.21 | −$368.4K | −2.5%1.53M after | |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Elanco Animal Health Inc10% Owner | PPurchaseCommon Stock, par value $0.0001 | +45.5M | $9.25 | +$421.0M | New position10.0K after |